Hu F - Search Results

1

Clinical and prognostic analyses of 110 patients with N3 nasopharyngeal carcinoma.

Chen J, Liu T, Sun Q, Hu F. Chen J, et al. Among authors: hu f. Medicine (Baltimore). 2018 Dec;97(49):e13483. doi: 10.1097/MD.0000000000013483. Medicine (Baltimore). 2018. PMID: 30544441 Free PMC article.

2

Clinical and prognostic analysis in 32 pediatric nasopharyngeal carcinoma.

Chen J, Hu F. Chen J, et al. Among authors: hu f. J Cancer Res Ther. 2015 Oct;11 Suppl 2:C226-9. doi: 10.4103/0973-1482.168191. J Cancer Res Ther. 2015. PMID: 26506882 Free article.

3

Neoadjuvant Chemotherapy with Fluorouracil plus Nedaplatin or Cisplatin for Locally Advanced Nasopharyngeal Carcinoma: a Retrospective Study.

Liu T, Sun Q, Chen J, Li B, Qin W, Wang F, Ye Z, Hu F. Liu T, et al. Among authors: hu f. J Cancer. 2018 Sep 8;9(20):3676-3682. doi: 10.7150/jca.27198. eCollection 2018. J Cancer. 2018. PMID: 30405836 Free PMC article.

4

A comparison of neoadjuvant chemotherapy with gemcitabine versus docetaxel plus cisplatin in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis.

Liu T, Sun Q, Chen J, Wang F, Li B, Qin W, Ye Z, Hu F. Liu T, et al. Among authors: hu f. Cancer Manag Res. 2018 Nov 23;10:6237-6245. doi: 10.2147/CMAR.S186233. eCollection 2018. Cancer Manag Res. 2018. PMID: 30538570 Free PMC article.

5

Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.

Ye Z, Wang F, Yan F, Wang L, Li B, Liu T, Hu F, Jiang M, Li W, Fu Z. Ye Z, et al. Among authors: hu f. World J Surg Oncol. 2019 Apr 1;17(1):60. doi: 10.1186/s12957-019-1605-9. World J Surg Oncol. 2019. PMID: 30935420 Free PMC article.

6

Identification of candidate genes of nasopharyngeal carcinoma by bioinformatical analysis.

Ye Z, Wang F, Yan F, Wang L, Li B, Liu T, Hu F, Jiang M, Fu Z. Ye Z, et al. Among authors: hu f. Arch Oral Biol. 2019 Oct;106:104478. doi: 10.1016/j.archoralbio.2019.07.003. Epub 2019 Jul 5. Arch Oral Biol. 2019. PMID: 31319350

7

Downregulation of miR‑429 and inhibition of cell migration and invasion in nasopharyngeal carcinoma.

Wang F, Jiang C, Sun Q, Yan F, Wang L, Fu Z, Liu T, Hu F. Wang F, et al. Among authors: hu f. Mol Med Rep. 2016 Apr;13(4):3236-42. doi: 10.3892/mmr.2016.4940. Epub 2016 Feb 23. Mol Med Rep. 2016. PMID: 26936585

8

miR-195 is a key regulator of Raf1 in thyroid cancer.

Wang F, Jiang C, Sun Q, Yan F, Wang L, Fu Z, Liu T, Hu F. Wang F, et al. Among authors: hu f. Onco Targets Ther. 2015 Oct 20;8:3021-8. doi: 10.2147/OTT.S90710. eCollection 2015. Onco Targets Ther. 2015. PMID: 26527888 Free PMC article.

9

Unfavorable clinical implications of circulating CD44+ lymphocytes in patients with nasopharyngeal carcinoma undergoing radiochemotherapy.

Hu FJ, Ge MH, Li P, Wang CC, Ling YT, Mao WM, Ling ZQ. Hu FJ, et al. Clin Chim Acta. 2012 Jan 18;413(1-2):213-8. doi: 10.1016/j.cca.2011.09.026. Epub 2011 Sep 29. Clin Chim Acta. 2012. PMID: 21983162

10

Arterial interventional chemotherapy and IMRT with concurrent chemotherapy for nasopharyngeal carcinoma with intracranial involvement.

Fen X, Qin W, Bao W, Jiang F, Li B, Hu F, Chen X. Fen X, et al. Among authors: hu f. Oncol Lett. 2013 Aug;6(2):427-431. doi: 10.3892/ol.2013.1407. Epub 2013 Jun 17. Oncol Lett. 2013. PMID: 24137340 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,591 results

Search Page

Filters